Literature DB >> 2645958

Paroxysmal nocturnal haemoglobinuria.

B Rotoli, L Luzzatto.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2645958     DOI： 10.1016/s0950-3536(89)80010-1

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN： 0950-3536


× No keyword cloud information.
  32 in total

1.  Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.

Authors:  D J Araten; K Nafa; K Pakdeesuwan; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.

Authors:  V Rosti; G Tremml; V Soares; P P Pandolfi; L Luzzatto; M Bessler
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation.

Authors:  Kohei Hosokawa; Takamasa Katagiri; Naomi Sugimori; Ken Ishiyama; Yumi Sasaki; Yu Seiki; Aiko Sato-Otsubo; Masashi Sanada; Seishi Ogawa; Shinji Nakao
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

Review 4.  New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.

Authors:  Tatsuya Kawaguchi; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

5.  Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Norimitsu Inoue; Tomohisa Izui-Sarumaru; Yoshiko Murakami; Yuichi Endo; Jun-Ichi Nishimura; Ken Kurokawa; Maki Kuwayama; Hiroaki Shime; Takashi Machii; Yuzuru Kanakura; Gabrielle Meyers; Carl Wittwer; Zhong Chen; William Babcock; Debra Frei-Lahr; Charles J Parker; Taroh Kinoshita
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

6.  CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Authors:  Tae-Hoon Shin; Eun Jung Baek; Marcus A F Corat; Shirley Chen; Jean-Yves Metais; Aisha A AlJanahi; Yifan Zhou; Robert E Donahue; Kyung-Rok Yu; Cynthia E Dunbar
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

7.  No evidence of hypermutability in red cells from patients with paroxysmal nocturnal hemoglobinuria using the XK gene.

Authors:  David J Araten; Leah Zamechek; Gregory Halverson
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 8.  Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; Antonio M Risitano; John D Lambris
Journal:  Semin Hematol       Date:  2018-02-14       Impact factor: 3.851

Review 9.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

10.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.